7% to 67.3% of subjects. This result indicates that atypical symptoms were not rare, but were more common than we expected in our subject population. The prevalence of asymptomatic RE in healthy individuals

has been reported as between 6% and 23%.10 Recently, some studies of subjects undergoing routine health checks in Asian countries have been published. A study from Korea reported that the Selleckchem Volasertib prevalence of RE was 6%, with 45.3% asymptomatic.8 Two studies from China and Taiwan reported that 4.3% and 33.6% of cases of erosive esophagitis were asymptomatic,11 and the prevalence of erosive esophagitis in asymptomatic subjects was 12%.9 Nozu and Komiyama reported that the frequency of asymptomatic RE was 26.4% in patients with RE.5 Murao et al., employing a QUEST cut-off score of 6 points, reported frequencies of asymptomatic esophageal reflux disease (ERD), symptomatic ERD and NERD were

34.8%, 13.6% and 51.6%, respectively among GERD patients.4 In this study, the prevalence of RE was 6.1% of all subjects undergoing EGD, with asymptomatic RE in ABT-737 solubility dmso 11.6% of subjects with RE. The frequency of asymptomatic RE was low compared with previous studies. A possible reason for this may be the fact that the subjects of this study were patients attending hospital with some complaint, our use of an FSSG score of zero to define asymptomatic RE. Obesity has been implicated in GERD,12 and some studies have identified a correlation between asymptomatic RE and BMI. Wang et al. stated that a high BMI is an independent risk factor for erosive

esophagitis in asymptomatic subjects.9 In contrast, another study stated that a low BMI is an independent risk factor associated with asymptomatic esophagitis.5 In this study, we found no association between asymptomatic RE and BMI. As there were only 14 subjects with RE who were also obese (BMI > 30), the contribution of BMI is selleck inhibitor necessarily obscure in this particular subject population. Our results indicate that asymptomatic RE was significantly more common in older subjects than symptomatic RE, in agreement with some earlier studies. In one study, elderly patients with endoscopically diagnosed RE had a significantly lower prevalence of typical gastroesophageal reflux symptoms than young and adult patients.13 Another large-scale study found that the prevalence of severe erosive esophagitis increases with age, but the severity of heartburn symptoms is an unreliable indicator of the severity of erosive disease.14 Franceschi et al. reported that in elderly patients with gastrointestinal disorders symptoms may be slight or atypical, resulting in a delayed diagnosis.15 Maekawa et al. compared reflux symptoms between elderly and younger patients with RE, concluding that since elderly patients with mild RE were less symptomatic than younger patients, mild RE in the elderly can go undiagnosed.16 These studies indicate that elderly patients are less likely to report symptoms than younger patients.